Jacquelot, N., Seillet, C., Wang, M., Pizzolla, A., Liao, Y., Hediyeh-zadeh, S., . . . Belz, G. T. (2021). Blockade of the co-inhibitory molecule PD-1 unleashes ILC2-dependent antitumor immunity in melanoma. Nature immunology, 22(7), 851-864. https://doi.org/10.1038/s41590-021-00943-z
Chicago Style (17th ed.) CitationJacquelot, Nicolas, et al. "Blockade of the Co-inhibitory Molecule PD-1 Unleashes ILC2-dependent Antitumor Immunity in Melanoma." Nature Immunology 22, no. 7 (2021): 851-864. https://doi.org/10.1038/s41590-021-00943-z.
MLA (9th ed.) CitationJacquelot, Nicolas, et al. "Blockade of the Co-inhibitory Molecule PD-1 Unleashes ILC2-dependent Antitumor Immunity in Melanoma." Nature Immunology, vol. 22, no. 7, 2021, pp. 851-864, https://doi.org/10.1038/s41590-021-00943-z.